Date: Wednesday, April 16, 2025
Time: 3pm – 4pm, Korea time
Solutions: Discovery
Services: Drug Development Services
Products: Chemaxon
Overview
This webinar is available only in Korean.
In today’s fast-paced innovation landscape, leveraging patent data has become vital for staying ahead in competitive markets, especially in the fields of material and life sciences. This webinar explores how ChemAxon’s cutting-edge software, ChemCurator, and Zifo’s expertise unlock the true potential of patent data. By focusing on competitive analysis, we’ll demonstrate how to extract and analyze complex chemical structures, including Markush structures, in a fast and accurate manner.
You’ll learn how ChemCurator streamlines the extraction of key data from patents, while Zifo enhances the curation process using both expert knowledge and GenAI technologies. Together, these solutions enable actionable insights for strategic decision-making, whether you’re exploring innovation opportunities or decoding competitor strategies. Real-world examples will illustrate how these tools have been applied to analyze battery materials in materials. Additionally, we’ll highlight how ChemAxon and Zifo collaborate to provide comprehensive solutions tailored to your needs.
Join us to discover how patent data analysis can transform your R&D, empower innovation, and give your organization a significant competitive edge.
Register
Note
Your contact information will be shared with Chemaxon’s partners in Korea, Zifo, and TNJ Tech, for the purpose of customer support and engagement activities.
Consultant, Zifo
Dr. Hanjo Kim is a seasoned cheminformatics researcher and consultant with over twenty years of experience in pharmaceutical and academic sectors. He holds a Ph.D. in Organic Chemistry from Yonsei University, specializing in artemisinin derivatives. Previously, he led global strategy and medicinal chemistry at Standigm, enhancing drug discovery with AI. At CJ Healthcare, he developed innovative molecular modeling systems.
Currently, he consults for Zifo, advising pharmaceutical companies on information management for drug discovery. An active contributor to scientific literature, he is recognized for his expertise in integrating chemistry and technology in the pharmaceutical industry.
Register
